FDA Inspection 1338568 — SHISEIDO AMERICAS CORPORATION
The FDA completed an inspection of SHISEIDO AMERICAS CORPORATION on Aug 21, 2026 in Groveport, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Groveport, OH (United States)